Jaundice: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 3 users not shown)
Line 3: Line 3:
   Name          = Jaundice, NOS |
   Name          = Jaundice, NOS |
   Image          = PHIL 2860 lores.jpg|
   Image          = PHIL 2860 lores.jpg|
   Caption        = Yellowing of the [[skin]] and [[sclera]] caused by [[Hepatitis|Hepatitis A]].|
   Caption        = Yellowing of the [[skin]] and [[sclera]], via Wikimedia Commons<ref>By Photo Credit: Content Providers(s): CDC/Dr. Thomas F. Sellers/Emory University [Public domain], <"https://commons.wikimedia.org/wiki/File%3AJaundice_eye.jpg"></ref>|
}}
}}


Line 10: Line 10:
'''For the approach to a patient with jaundice, click [[Approach to a patient with jaundice|here]].'''
'''For the approach to a patient with jaundice, click [[Approach to a patient with jaundice|here]].'''


{{CMG}} '''Associate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{FKH}}, {{FA}}, {{EG}}, {{MJ}}


{{Jaundice}}
{{Jaundice}}


'''''Synonyms and keywords:''''' Icterus; hyperbilirubinemia.
'''''Synonyms and keywords:''''' Icterus; hyperbilirubinemia, yellow discolouration.


==[[Jaundice overview|Overview]]==
==[[Jaundice overview|Overview]]==
Line 21: Line 21:


==[[Jaundice classification scheme|Classification]]==
==[[Jaundice classification scheme|Classification]]==
[[Neonatal jaundice]] | [[Prehepatic jaundice]] | [[Hepatic jaundice]] | [[Posthepatic jaundice]]


==[[Jaundice pathophysiology|Pathophysiology]]==
==[[Jaundice pathophysiology|Pathophysiology]]==
Line 50: Line 49:
*[[Cholestasis]]
*[[Cholestasis]]
*[[Bilirubin]]
*[[Bilirubin]]
==References==
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
<references />


[[Category:Primary care]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 22:26, 29 July 2020

Template:DiseaseDisorder infobox

For patient information, click here.

For the approach to a patient with jaundice, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Farnaz Khalighinejad, MD [2], Fatima Shaukat, MD [3], Eiman Ghaffarpasand, M.D. [4], Mehrian Jafarizade, M.D [5]

Jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Jaundice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Jaundice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Jaundice

CDC on Jaundice

Jaundice in the news

Blogs on Jaundice

Directions to Hospitals Treating Jaundice

Risk calculators and risk factors for Jaundice

Synonyms and keywords: Icterus; hyperbilirubinemia, yellow discolouration.

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

References

Template:WikiDoc Sources